Noah Lubin, MD

Article
Semaglutide Reduces Alcohol Use in Patients with Obesity Seeking Treatment for Alcohol Use Disorder
October 1, 2026
Clinical Question: Can GLP-1 receptor agonists be used to reduce alcohol use in obese patients motivated to reduce alcohol consumption? Background: Alcohol use disorder accounts for 2.6 million...